GOP Rep. Chris Collins allegedly engaged in insider trading from the White House lawn

While his fellow members of Congress were enjoying carousel rides on the White House lawn, Rep. Chris Collins (R-N.Y.) was apparently learning the company he'd invested millions in was about to fail.

The congressman and longtime President Trump fan was a top shareholder in Innate Immunotherapeutics, and he lost $17 million when it was revealed the Australian biotech company's star drug didn't pass clinical trials. But as an Innate board member, Collins learned about the failure before it went public — and told his son to sell his shares before he suffered similar losses, court filings released Wednesday allege. And it all happened while Collins was at the annual White House congressional picnic.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Kathryn Krawczyk

Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.